Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

Phage therapy is recognized as a promising alternative to antibiotics in treating pulmonary bacterial infections, however, its use has not been reported for treating secondary bacterial infections during virus pandemics such as coronavirus disease 2019 (COVID-19). We enrolled 4 patients hospitalized...

Full description

Bibliographic Details
Main Authors: Nannan Wu, Jia Dai, Mingquan Guo, Jianhui Li, Xin Zhou, Feng Li, Yuan Gao, Hongping Qu, Hongzhou Lu, Jing Jin, Tao Li, Lei Shi, Qingguo Wu, Ruoming Tan, Mingli Zhu, Lan Yang, Yun Ling, Shunpeng Xing, Jianzhong Zhang, Bangxin Yao, Shuai Le, Jingmin Gu, Jinhong Qin, Jie Li, Mengjun Cheng, Demeng Tan, Linlin Li, Yiyuan Zhang, Zhaoqin Zhu, Jinfeng Cai, Zhigang Song, Xiaokui Guo, Li-Kuang Chen, Tongyu Zhu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Emerging Microbes and Infections
Subjects:
Phage therapy
carbapenem-resistant Acinetobacter baumannii
nosocomial infections
COVID-19
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2021.1902754

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2021.1902754

Similar Items